EIVDX
Price
$14.34
Change
-$0.35 (-2.38%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

EIVDX vs RMFCX

Header iconEIVDX vs RMFCX Comparison
Open Charts EIVDX vs RMFCXBanner chart's image
Allspring Special Large Cap Value Admin
Price$14.34
Change-$0.35 (-2.38%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
EIVDX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EIVDX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EIVDX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. EIVDX (1.32B). RMFCX pays higher dividends than EIVDX: RMFCX (1.69) vs EIVDX (0.82). EIVDX was incepted earlier than RMFCX: EIVDX (14 years) vs RMFCX (23 years). EIVDX is a more actively managed with annual turnover of: 42.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than EIVDX: RMFCX (250) vs EIVDX (1000000). RMFCX (12.63) and EIVDX (12.39) have marching annual gain over last year. RMFCX return over 5 years is better than : 40.39 vs. EIVDX (11.14).
EIVDXRMFCXEIVDX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years23 years-
Gain YTD10.78411.42394%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.32B98.7B1%
Annual Yield % from dividends0.821.6948%
Returns for 1 year12.3912.6398%
Returns for 3 years10.2114.1672%
Returns for 5 years11.1440.3928%
Returns for 10 years12.2361.8420%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc